HB Human BioScience is a leading multinational enterprise specialized in research & development as well as   the manufacturing of medicine for critical care therapies.
HB Human Bioscience aims at the betterment of the health and well-being of people, through the implementation of state-of-the-art technology and cutting edge methods to the production of our medicine. Our products are certified by the most important pharmaceutical regulatory authorities in the world; namely, WHO, USFDA, MHRA,UK, EMEA, ORGANIZACION PANAMERICANA DE LA SALUD, and INVIMA.
HB Human BioScience imports the best medicine products from the most recognized laboratories around the world. HB Human BioScience also develops molecules to create its own medicines and introduce them into de pharmaceutical industry.
HB Human BioSience specializes also in “Orphan Drugs” which are pharmaceutical agents that have been developed specifically to treat rare medical conditions, referred to as an” orphan diseases”.  Due to their low returns or high costs many “Orphan drugs” are not always available or sufficient in many countries.  Orphan Diseases are rare diseases with an average prevalence of less than 5 cases per 10,000 inhabitants. These are usually genetic diseases and/or life threatening conditions. Today certain drugs exist for those treatments however due to the rarity of the diseases it is usually impractical to procure licenses to import however Human Bioscience has implemented an infrastructure to deliver these medicines to thousands of patients worldwide who are suffering from these conditions.
Other fields in which HB Human Bioscience stands out are in the development of Active Principles, Bioequivalences and New Medicines. Towards this end HB Human Bioscience works closely with a great team of prestigious scientists who apply their knowledge and technology to produce better and safer medicines to heal or prolong the life of thousands of patients.
HB Human BioScience’s innovative pharmacy products focus on the treatment of high risk patients in the fields of Oncology, Cardiology, Transplants, HIV, Rheumatism, Anesthesia, Broad Spectrum Antibiotics and Kidney failure, Hemophilia among others.
Because of HB Human  BioScience efforts, low prices, and good results, more patients around the world, can access highly specialized and expensive treatments.  We deliver products that not only make a difference but also save lives.

HB Human BioScience is a leading multinational enterprise specialized in research & development as well as   the manufacturing of medicine for critical care therapies.
HB Human Bioscience aims at the betterment of the health and well-being of people, through the implementation of high technology and cutting edge methods to the production of our medicine. Our products are certified by the most important pharmaceutical regulatory authorities in the world; namely, WHO, USFDA, MHRA, EMEA, ORGANIZACION PANAMERICANA DE LA SALUD, and INVIMA.
HB Human BioScience imports the best medicine products from the most recognized laboratories around the world. HB Human BioScience also develops molecules to create its own medicines and introduce them into de pharmaceutical industry.
HB Human BioSience specializes also in “Orphan Drugs” which are pharmaceutical agents that have been developed specifically to treat rare medical conditions, referred to as an” orphan diseases”.  Due to their low returns or high costs many “Orphan drugs” are not always available or sufficient in many countries.  Orphan Diseases are rare diseases with an average prevalence of less than 5 cases per 10,000 inhabitants. These are usually genetic diseases and/or life threatening conditions. Today certain drugs exist for those treatments however due to the rarity of the diseases it is usually impractical to procure licenses to import however Human Bioscience has implemented an infrastructure to deliver these medicines to thousands of patients worldwide who are suffering from these conditions.
Other fields in which HB Human Bioscience stands out are in the development of Active Principles, Bioequivalences and New Medicines. To this en HB Human Bioscience works closely with a great team of prestigious scientists who apply their knowledge and technology to produce better and safer medicines to heal or prolong the life of thousands of patients.
HB Human BioScience’s innovative Pharmacy products focus on the treatment of high risk patients in the fields of Oncology, Cardiology, Transplants, HIV, Rheumatism, Anesthesia, Broad Spectrum Antibiotics and Kidney failure, Hemophilia among others.
Because of HB Human  BioScience support, low prices, and good results, more patients around the world, can access highly specialized and expensive treatments.  We deliver products that not only make a difference but also save lives.

Latest news

Read more

Opening Positions

Head office: South America

Cra 12 #96-81 Oficina 301 Bogotá D.C, Colombia

(+57) 1 7437022

Head office: India

Level 4, A-Wing Dynasty Business Park, Andheri Kurla Road, Andheri (east) Mumbai 400 059 India

+ 91 22 67869594

Head office: USA

3537 NW Clubside Circle. Boca Raton Florida 33496

(+1) 5615421872

Head office: Venezuela

Altamira Av. San Juan Bosco. Building San Juan Floor 4 office. 4A.

(+2) 124250017

Head Office: Perú

Calle Ernesto Plascencia No. 361 Distrito de San Isidro - Lima

(+51) 1 2222777

Head Office: Ecuador

Manuel Iturrey N28-05 entre Coruña y Bello Horizonte. Edificio Artes- 4to piso Quito - Ecuador

(593-2) 2547-776/ 2521-318/ 2556-809

Head Office: Chile

Av. Los Conquistadores 1700 piso 11 Providencia - Santiago de Chile

(+56) 2 22338266

Política de Tratamiento de Datos Personales Consulta o reclamo sobre el tratamiento de datos personales